April 1972

Detection of HAA in the Serum of Patients With Primary Carcinoma of the Liver

Author Affiliations

Nice, France; New York; Lyon, France; New York
From the Laboratoire de Biochimie Médicale, Ecole Nationale de Medecine, Nice, France (Dr. Masseyeff), New York Blood Center, New York (Drs. Prince and Szmuness), and the International Agency for Research on Cancer, Lyon, France (Dr. Leblanc).

Am J Dis Child. 1972;123(4):412-413. doi:10.1001/archpedi.1972.02110100144055

The incidence of primary liver cancer (PLC) varies widely in different areas of the world. It is an important disease in India, in the Far East, and especially in parts of subsaharan Africa. Although seldom seen in Europe and in America, the estimated incidence is three per 10,000 in Senegal where the present study was made. It accounts for 24% of all cancer in men and 5% in women, while in Europe this proportion does not exceed 1% to 3% according to the most recent statistics, standardized for age.1

The cause(s) of PLC that might explain this special geographic distribution remain unknown. Several hypotheses have been advanced. Malnutrition has few supporters, while genetic predisposition possibly would have only a contributing effect. The most popular hypothesis is that food contains hepatocarcinogenic substances, such as cycasin, pyrolizidine alkaloids, and especially aflatoxin.2 Some investigators have advanced an oncogenic role for the

First Page Preview View Large
First page PDF preview
First page PDF preview